Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma

Lancet

Volumn 359, Issue 9310, 2002, Pages 943-945

  Würl, Peter ^a   Kappler, Matthias ^b   Meye, Axel ^c   Bartel, Frank ^b   Köhler, Thomas ^d   Lautenschläger, Christine ^b   Bache, Matthias ^b   Schmidt, Hannelore ^b   Taubert, Helge ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d Roboscreen Gesellschaft Für Molekulare Biotechnologie Mbh   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SOFT TISSUE SARCOMA; TUMOR LOCALIZATION;

EID: 0037117121     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07990-4     Document Type: Article

References (5)

1. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
2. Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients
3. Telomerase activity in soft-tissue and bone sarcomas
4. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
5. High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas